Should We Use bDMARDs as an Induction Therapy in Early and Severe Rheumatoid Arthritis? Results at 5 years from the ERA UCLouvain Brussels Cohort.

Emilie SapartTatiana SokolovaStéphanie de MontjoyeStéphanie DierckxAdrien NzeusseuAleksandra AvramovskaLaurent Meric de BellefonPatrick Durez

Published in: Rheumatology and therapy (2023)

Long-term remission is an achievable goal in ERA. Our results suggest that a bDMARD induction therapy followed by MTX maintenance therapy could be an interesting option.

Keyphrases

rheumatoid arthritis
disease activity
systemic lupus erythematosus
idiopathic pulmonary fibrosis
smoking cessation
drug induced
replacement therapy